Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Esperion Therapeutics Inc (NASDAQ:ESPR)

48.36
BATS BZX Real-Time Price
As of 12:05pm ET
 +4.62 / +10.56%
Today’s Change
9.40
Today|||52-Week Range
48.54
+286.26%
Year-to-Date

Today’s Trading

Previous close43.74
Today’s open44.44
Day’s range44.21 - 48.54
Volume43,632
Average volume (3 months)1,665,887
Market cap$988.1M
Dividend yield--
Data as of 12:05pm ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-47.35%
Earnings growth (this year)-105.22%
Earnings growth (next 5 years)-5.76%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.32

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.03+0.68%
OMEROmeros Corp-1.78-7.92%
FWPForward Pharma A/S-0.03-0.15%
ATNXAthenex Inc+0.83+4.89%
Data as of 12:06pm ET, 06/28/2017

Financials

Next reporting dateAugust 15, 2017
EPS forecast (this quarter)-$1.62
Annual revenue (last year)$0.00
Annual profit (last year)-$75.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tim M. Mayleben
COO, Executive VP-Research &
Development
Narendra D. Lalwani
Corporate headquarters
Ann Arbor, Michigan

Forecasts